Ethics and Confidentiality | David Kan, MD
This lecture covers ethical issues relating to the treatment of substance use disorders. Confidentiality issues, including federal regulations, those relating to adolescents, use of EMR, and implications of Tarasoff are covered.
PRICE/PURCHASE -- $50
You must sign in or register register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of .75 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 0.75 AMA/PRA Category 1 Credits™ for completing the Review Course.
Continuing education credit is also available for nurses, psychologists, pharmacists, physician assistants, therapists, and drug abuse counselors.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
At the end of this activity the learner should be more competent in applying appropriate ethical and confidentiality principles, laws and regulations to the practice of addiction medicine, including the following:
- HIPPA regulations pertaining to confidentiality, for under-age minor versus adult patients, specifically concerning addiction and mental health disorders.
- Concepts and regulations relating to record-keeping, patient privacy and security of records, including the limitations and privacy expectations of 42CFR in integrated settings.
- Discussion of ethical issues specific to the field of addiction medicine.
David Kan, MD
David Kan is in the solo private practice of Addiction, General and Forensic Psychiatry. He has recently become the Medical Director of Bright Heart Health addiction treatment unit. He is an active member of CSAM serving on the Public Policy and Chairs the Opioid Committee. He is also CSAM's President-Elect. He is on the clinical faculty at UC San Francisco where he supervises Addiction and Forensic Fellows. He has been retained as an expert witness in over one hundred cases during his career. Dr. Kan has been leading an ongoing conversation between CSAM and California's Insurance plans to increase the standards for essential health benefits to align with the evidence base for the treatment of addictive disorders.
Dr. Kan has no relevant financial relationships to disclose.
- 0.75 AMA Category 1
- 0.75 Attendance